hsa-mir-4435: Hsa-mir-4435 is a microRNA (miRNA) implicated in various biological processes and diseases, including breast cancer and hepatocellular carcinoma (HCC) [PMC8158160; PMC9820840]. In breast cancer, hsa-mir-4435 was identified as a potential prognostic biomarker, as its dysregulation was significantly related to the overall survival (OS) of patients [PMC8158160]. However, hsa-mir-4435 did not show differential expression between cancerous and paired paracancerous tissues in breast cancer patients [PMC8158160]. Additionally, hsa-mir-4435 was not evaluated in the comparison of expression levels between high and low metastatic cell lines due to a lack of data [PMC8158160]. In the context of multiple sclerosis (MS), hsa-mir-4435 expression is specific to B cells and not expressed in lymphoblastoid cell lines (LCLs), suggesting its context-specific regulatory role [PMC8000127]. Furthermore, hsa-mir-4435 targets several disease-related genes, indicating its regulatory importance in disease progression such as diabetic retinopathy (DR) [PMC8545528]. The host gene of hsa-mir-4435 is MIR4435-2HG, which contains several single nucleotide polymorphisms (SNPs) within transcription factor binding sites (TFBS), suggesting potential regulatory mechanisms at the genetic level [PMC8545528]. Hsa-mir-4435 has also been associated with pregnancy complications, indicating its role beyond oncology into reproductive health [PMC8539647].